ImmunityBio
IBRX
#3180
Rank
$3.61 B
Marketcap
$5.37
Share price
-1.65%
Change (1 day)
223.49%
Change (1 year)

Operating Margin for ImmunityBio (IBRX)

Operating Margin as of March 2024 (TTM): -147,405.00%

According to ImmunityBio's latest financial reports and stock price the company's current Operating Margin is -147,405.00%. At the end of 2021 the company had an Operating Margin of -37,456.00%.

Operating Margin history for ImmunityBio from 2020 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-37,456.00%0.25%
2020-37,360.83%413.33%
2019-7,278.07%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.